Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitosis pathway is the process by which a eukaryotic cell divides its nucleus and genetic material, resulting in two genetically identical daughter cells. This pathway is essential for growth, tissue repair, and asexual reproduction in multicellular organisms. It involves a series of distinct phases (prophase, prometaphase, metaphase, anaphase, telophase, and cytokinesis) that ensure precise segregation of chromosomes. Regulation is achieved through checkpoints, CDKs, and other signaling pathways. Dysregulation of this pathway is a hallmark of cancer, and many anti-cancer drugs target specific proteins involved in mitosis.
Various, depending on the specific drug. Examples include: Microtubule stabilization (taxanes), microtubule destabilization (vinca alkaloids), inhibition of kinases involved in cell cycle progression (CDK inhibitors, Aurora kinase inhibitors).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitosis Pathway.